Yuki Kagoya
Shinjuku, 1608582, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Development of memory-like CAR-NK cells with durable antitumor activity
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Identification of a shared antigen linking CD4+ T and B cell pathology in Sjögren's disease.
Journal: Science advances
Published: June 03, 2026
Distinct roles of STAT3 and STAT5 in CAR T cell therapy.
Journal: Molecular therapy. Oncology
Published: May 25, 2026
Strategies to overcome CAR-T cell exhaustion and terminal differentiation
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026
Bispecific antibodies: current advances and future perspectives.
Journal: International immunology
Published: May 10, 2026
CD28-driven ex vivo generation of stem-like memory CD8+ T cells bypassing CD3/TCR signaling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 21, 2026
Novel cancer immunotherapy using cell-derived membrane vesicles loaded with multiple immunomodulatory factors
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: February 01, 2026
Computational optimization of chimeric antigen receptor.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 01, 2025
Efficient expansion of tumor-infiltrating lymphocytes from gynecologic cancer.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 23, 2025
JAK-STAT-activated, fratricide-resistant CAR-T cells targeting membrane-bound TNF effectively treat AML and solid tumors.
Journal: Journal for immunotherapy of cancer
Published: June 28, 2025
CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles.
Journal: Blood cancer discovery
Published: June 23, 2025
Constitutive STAT3 Signaling, in Comparison with STAT5, Enhances CAR T-cell Efficacy and Lowers Systemic Toxicity.
Journal: Cancer immunology research
Published: May 14, 2025
Last Updated: 09/26/2026